Correlation Between Sarofim Equity and Deutsche Health

Can any of the company-specific risk be diversified away by investing in both Sarofim Equity and Deutsche Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarofim Equity and Deutsche Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sarofim Equity and Deutsche Health And, you can compare the effects of market volatilities on Sarofim Equity and Deutsche Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarofim Equity with a short position of Deutsche Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarofim Equity and Deutsche Health.

Diversification Opportunities for Sarofim Equity and Deutsche Health

0.03

Correlation Coefficient

Sarofim Equity  Deutsche Health

Significant diversification

The 3 months correlation between Sarofim and DEUTSCHE is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Sarofim Equity and Deutsche Health And in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Deutsche Health And and Sarofim Equity is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarofim Equity are associated (or correlated) with Deutsche Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Deutsche Health And has no effect on the direction of Sarofim Equity i.e., Sarofim Equity and Deutsche Health go up and down completely randomly.

Pair Corralation between Sarofim Equity and Deutsche Health

Assuming the 90 days horizon Sarofim Equity is expected to under-perform the Deutsche Health. In addition to that, Sarofim Equity is 1.21 times more volatile than Deutsche Health And. It trades about -0.07 of its total potential returns per unit of risk. Deutsche Health And is currently generating about 0.09 per unit of volatility. If you would invest  4,056  in Deutsche Health And on December 29, 2024 and sell it today you would earn a total of  166.00  from holding Deutsche Health And or generate 4.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Sarofim Equity  vs.  Deutsche Health And

Sarofim Equity

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sarofim Equity has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong primary indicators, Sarofim Equity is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Deutsche Health And

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Deutsche Health And are ranked lower than 6 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong essential indicators, Deutsche Health is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Sarofim Equity and Deutsche Health

The main advantage of trading using opposite Sarofim Equity and Deutsche Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarofim Equity position performs unexpectedly, Deutsche Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Deutsche Health will offset losses from the drop in Deutsche Health's long position.

The idea behind Sarofim Equity and Deutsche Health And pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.